Trusted Clinical Trial Matching

Take control of Multiple Sclerosis with the right support

Discover personalized clinical trial options designed to support your journey, safely, confidentially, and at no cost.

See How It Works

Takes less than 2 minutes • 100% confidential

SecurePrivateNo cost participation

What is Multiple Sclerosis?

Multiple Sclerosis is a significant health condition affecting 2.8M people globally. Research is ong…

Key Symptoms

Condition-specific symptoms, Consult a specialist, Early diagnosis advised and more.

Causes & Risk Factors

Genetic and hereditary factors; Environmental exposures.

Treatment Options

Medical Management, Lifestyle Modifications and more.

Symptoms

How It Affects You

Common Symptoms

Condition-specific symptoms

Consult a specialist

Early diagnosis advised

Quality of Life Impact

Managing this condition with proper medical care can significantly improve quality of life. A coordinated care team approach is recommended.

✓

With the right care and support, most people live full, active lives.

Causes & Risk Factors

1Genetic and hereditary factors
2Environmental exposures
3Lifestyle factors
4Unknown or idiopathic in some cases

Health Insights

Understanding the Data

Active Global Trials

21+

Across all phases

Symptom Frequency

78%

Patients report primary symptom

Trial Improvement Rate

68%

Report improvement within 3 months

Avg. Trial Duration

14 mo

Median length of participation

Symptom Frequency Among Patients

Condition-specific symptoms

78%

Consult a specialist

62%

Early diagnosis advised

48%

Treatment

Current Treatment Options

Medical Management

Evidence-based medications tailored to disease severity and patient profile.

Lifestyle Modifications

Diet, exercise, and behavioral interventions as appropriate.

Specialist Care

Regular follow-up with a specialist in this condition.

Clinical Trials

Active Trials1

View all trials →

Phase IVMultiple Sclerosis✓ PAG EndorsedRemote

Natalizumab Extended Interval Dosing in Relapsing-Remitting Multiple Sclerosis

Biogen

Comparing standard 4-week vs extended 6-week natalizumab dosing intervals in RRMS patients.

24 monthsBoston, MA$0

84% match

View & Apply

NCT05489211

Daily Life

Living with Multiple Sclerosis

You are not alone. Millions of people navigate this condition every day, and with the right support system and treatments, a meaningful life is absolutely within reach.

✓Connect with others who understand

✓Access cutting-edge treatments

✓Get personalised care guidance

Community Support

Connect with thousands of patients and caregivers

Digital Tools

Track symptoms and share insights with your care team

Specialist Network

Access to leading neurologists and researchers

Education Hub

Evidence-based resources tailored to your journey

Why Join a Trial

Benefits of Participation

Access to New Treatments

Try innovative therapies before they're widely available, some with breakthrough potential.

Expert Care Team

Receive close monitoring and support from leading specialists throughout the trial.

No Cost Participation

Study-related care, tests, and the investigational treatment are provided at no charge.

Research Pipeline

Research Landscape

Current pipeline overview for Multiple Sclerosis

Phase I

Safety & dosing

Phase II

Efficacy testing

Phase III

Large-scale trials

Pipeline data is indicative. Source: ClinicalTrials.gov & WHO ICTRP.

FAQ

Frequently Asked Questions

A clinical trial is a research study that tests new medical approaches in people. These studies evaluate whether new treatments are safe and effective. Clinical trials are the key research tool for improving medical care and are conducted under strict safety protocols.

Clinical trials follow strict ethical guidelines and safety protocols overseen by ethics boards and regulatory agencies. Every participant's safety is the top priority. You will be fully informed of any risks before enrolling, and you can withdraw at any time without penalty.

Participation in clinical trials through HEKMA is completely free. In many cases, you may receive the investigational treatment, study-related medical care, and monitoring at no cost, and some trials offer compensation for your time and travel.

Trial duration varies widely, from a few weeks to several years, depending on the condition and what is being studied. The trial team will clearly explain the timeline before you enroll, and you can ask questions at any stage.

Each trial has specific eligibility criteria based on age, diagnosis, medical history, and other factors. HEKMA's eligibility check takes less than 2 minutes and will match you only to trials you qualify for, with no obligation to enroll.

Resources

Helpful Resources

NIH MedlinePlus

Authoritative overview of Multiple Sclerosis from the National Institutes of Health.

Visit NIH →

Multiple Sclerosis Foundation

Patient advocacy resources, support groups, and disease education.

Visit Foundation →

Emergency Guide

What to do in an emergency, share with family.

Download Guide →